Kyle Kuszpit

728 total citations
20 papers, 540 citations indexed

About

Kyle Kuszpit is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kyle Kuszpit has authored 20 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kyle Kuszpit's work include Neuroscience and Neuropharmacology Research (4 papers), MRI in cancer diagnosis (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Kyle Kuszpit is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), MRI in cancer diagnosis (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Kyle Kuszpit collaborates with scholars based in United States, Australia and Poland. Kyle Kuszpit's co-authors include Brian D. Ross, Timothy D. Johnson, Thomas L. Chenevert, Alnawaz Rehemtulla, Charles R. Meyer, Phillip Sherman, Michael R. Kilbourn, Kuei C. Lee, Kenneth Zasadny and Thomas Bocan and has published in prestigious journals such as Nature Communications, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Kyle Kuszpit

20 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Kuszpit United States 13 168 144 91 83 80 20 540
Wade Koba United States 15 91 0.5× 284 2.0× 75 0.8× 41 0.5× 129 1.6× 27 775
P. Krueger United States 13 93 0.6× 142 1.0× 19 0.2× 71 0.9× 72 0.9× 25 846
Nicholas Buss United States 12 219 1.3× 402 2.8× 22 0.2× 90 1.1× 70 0.9× 22 735
Jennifer A. Coccia United States 6 185 1.1× 251 1.7× 25 0.3× 112 1.3× 159 2.0× 14 774
François Berger France 11 112 0.7× 204 1.4× 22 0.2× 27 0.3× 35 0.4× 26 542
J. A. Belli United States 12 86 0.5× 238 1.7× 35 0.4× 73 0.9× 157 2.0× 21 680
Evelyne Dufour France 8 51 0.3× 186 1.3× 31 0.3× 33 0.4× 112 1.4× 8 583
Alessandra Spano Italy 16 26 0.2× 200 1.4× 50 0.5× 55 0.7× 24 0.3× 37 777
WooRam Jung South Korea 11 31 0.2× 306 2.1× 31 0.3× 73 0.9× 27 0.3× 15 607
Adam Lee Goldstein Israel 8 109 0.6× 238 1.7× 19 0.2× 16 0.2× 95 1.2× 29 717

Countries citing papers authored by Kyle Kuszpit

Since Specialization
Citations

This map shows the geographic impact of Kyle Kuszpit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Kuszpit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Kuszpit more than expected).

Fields of papers citing papers by Kyle Kuszpit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Kuszpit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Kuszpit. The network helps show where Kyle Kuszpit may publish in the future.

Co-authorship network of co-authors of Kyle Kuszpit

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Kuszpit. A scholar is included among the top collaborators of Kyle Kuszpit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Kuszpit. Kyle Kuszpit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laker, Rhianna C., Shaun Egolf, Sarah Will, et al.. (2025). GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice. Nature Communications. 16(1). 4714–4714. 1 indexed citations
2.
Kozak, Rouba, Tamás Kiss, David E. Johnson, et al.. (2020). Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Frontiers in Pharmacology. 11. 1005–1005. 18 indexed citations
3.
Li, Qing, Norman Peterson, Richard N. Hanna, et al.. (2019). Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention. Molecular Pharmaceutics. 17(2). 507–516. 9 indexed citations
4.
Rajamani, Sathish, Kyle Kuszpit, Jennifer L. Brown, et al.. (2018). Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics. Scientific Reports. 8(1). 12618–12618. 10 indexed citations
5.
Kuszpit, Kyle, et al.. (2018). Evaluation of Volume of Intramuscular Injection into the Caudal Thigh Muscles of Female and Male BALB/c Mice (Mus musculus).. PubMed. 57(1). 35–43. 13 indexed citations
6.
Kuszpit, Kyle, Bradley S. Hollidge, Xiankun Zeng, et al.. (2017). [18F]DPA-714 PET Imaging Reveals Global Neuroinflammation in Zika Virus-Infected Mice. Molecular Imaging and Biology. 20(2). 275–283. 16 indexed citations
7.
Smith, Darci R., Bradley S. Hollidge, Sharon P. Daye, et al.. (2017). Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon. PLoS neglected tropical diseases. 11(1). e0005296–e0005296. 90 indexed citations
8.
Skaddan, Marc B., Lei Zhang, Douglas S. Johnson, et al.. (2012). The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH). Nuclear Medicine and Biology. 39(7). 1058–1067. 25 indexed citations
9.
Zhang, Cathy C., Zhengming Yan, Wenlin Li, et al.. (2011). [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells. Clinical Cancer Research. 18(5). 1303–1312. 62 indexed citations
10.
Comery, Thomas A., Kenneth Zasadny, Evan D. Morris, et al.. (2011). P4‐253: Receptor occupancy of the 5‐HT6 receptor antagonist SAM‐760 in non‐human primates and healthy human volunteers. Alzheimer s & Dementia. 7(4S_Part_23). 1 indexed citations
11.
Zhang, Cathy C., Zhengming Yan, Qin Zhang, et al.. (2010). PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity. Clinical Cancer Research. 16(21). 5177–5188. 58 indexed citations
12.
Galbán, Craig J., Mahaveer S. Bhojani, Kuei C. Lee, et al.. (2010). Evaluation of Treatment-Associated Inflammatory Response on Diffusion-Weighted Magnetic Resonance Imaging and 2-[18F]-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Imaging Biomarkers. Clinical Cancer Research. 16(5). 1542–1552. 17 indexed citations
13.
Zhang, Cathy, Zhengming Yan, Cory L. Painter, et al.. (2009). PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts. Clinical Cancer Research. 15(14). 4630–4640. 45 indexed citations
14.
Schepkin, Victor D., Kuei C. Lee, Kyle Kuszpit, et al.. (2006). Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. NMR in Biomedicine. 19(8). 1035–1042. 28 indexed citations
15.
Schepkin, Victor D., Thomas L. Chenevert, Kyle Kuszpit, et al.. (2006). Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. Magnetic Resonance Imaging. 24(3). 273–278. 46 indexed citations
16.
Meyer, Charles R., Bradford A. Moffat, Kyle Kuszpit, et al.. (2006). A Methodology for Registration of a Histological Slide and In Vivo MRI Volume Based on Optimizing Mutual Information. Molecular Imaging. 5(1). 16–23. 60 indexed citations
17.
Kilbourn, Michael R., Phillip Sherman, & Kyle Kuszpit. (2001). In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies. Synapse. 43(3). 188–194. 6 indexed citations
18.
Dort, Marcian E. Van, et al.. (2001). Development of radioiodinated nonsteroidal androgen receptor ligands for spect imaging of prostate cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 1 indexed citations
19.
Dort, Marcian E. Van, et al.. (2001). Synthesis of a carbon‐11 labeled nonsteroidal antiandrogen as a potential radioligand for pet imaging of prostate cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 1 indexed citations
20.
Kilbourn, Michael R., Kyle Kuszpit, & Phillip Sherman. (2000). Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse. 35(4). 250–255. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026